Axsome Therapeutics, Inc. AXSM
148.56 USD +7.59 (+5.38%)
Nov 11, 2026, 2:35 PM EST
141.41 Day range 151.31
123.00 52-week range 260.19
- YTD
- -18.66%
- 1 year
- +6.41%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 638.50M | 385.69M | 270.60M | 50.04M | 0 | |
| 638.50M | 385.69M | 270.60M | 50.04M | 0 | |
| 47.48M | 33.30M | 26.07M | 5.20M | 0 | |
| 591.02M | 352.39M | 244.53M | 44.84M | 0 | |
| 757.78M | 632.95M | 476.36M | 224.64M | 124.71M | |
| 183.28M | 187.08M | 97.94M | 57.95M | 58.06M | |
| 570.60M | 411.36M | 323.12M | 159.25M | 66.65M | |
| -166.76M | -280.56M | -231.82M | -179.80M | -124.71M | |
| 6.56M | 6.57M | 6.45M | 7.33M | 5.70M | |
| -530.00K | 85.00K | 960.00K | 0 | 0 | |
| -183.17M | -287.22M | -239.24M | -187.13M | -130.40M | |
| -183.17M | -287.22M | -239.24M | -187.13M | -130.40M | |
| -183.17M | -287.22M | -239.24M | -187.13M | -130.40M | |
| -183.17M | -287.22M | -239.24M | -187.13M | -130.40M | |
| -3.68 | -5.99 | -5.27 | -4.60 | -3.47 | |
| -3.68 | -5.99 | -5.27 | -4.60 | -3.47 | |
| -3.68 | -5.99 | -5.27 | -4.60 | -3.47 | |
| -177.15M | -280.56M | -231.82M | -179.80M | -124.71M | |
| -177.15M | -280.56M | -231.82M | -179.80M | -124.71M | |
| 49.75M | 47.91M | 45.43M | 40.66M | 37.62M | |
| 49.75M | 47.91M | 45.43M | 40.66M | 37.62M |